PRODUCTION OF T-INDEPENDENT HIV 1 VACCINE
PRODUCTION OF T-INDEPENDENT HIV 1 VACCINE
批准号:
3811246
负责人:
H GOLDING
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In HIV I infected individuals, CD4-bearing T cells (T helper), are
functionally deficient early in the course of the infection and become
numerically depleted in advanced stages of the disease. In devising a
strategy for vaccinating HIV I infected individuals, we looked for means of
stimulating their B cells to produce HIV I specific antibodies under
conditions of limited T cell help. It was previously established in the
murine and human systems that certain "carriers" may convert an otherwise
T-dependent antigen into a T-independent antigen. One such carrier is the
inactivated bacterium Brucella abortus (Ba). Small haptens, when conjugated
to Ba, can elicit strong antibody responses in vivo which are dominated by
the IgGa+2b isotypes (which are most efficient in mediating Ab mediated
cytotoxicity). Furthermore, in humans haptens-Ba can stimulate both adult
and neonatal B cells to produce hapten specific Ab in the absence of T
cells. Inactivated HIV I was conjugated to Ba, and the conjugate formed
(HIV I-Ba) as well as unconjugated HIV I were tested for immunogenicity in
normal Balb/c mice and CD4-depleted Balb/c (anti L3T4 treated mice). Mice
immunized with HIV-Ba produced 2-3-fold higher titers of HIV I specific
antibodies compared to HIV I immunized mice. The Ab generated were
predominantly of the IgG2a in the HIV-BA immunized mice. The sera from both
mouse groups reacted with all the major viral proteins on Western blots.
Furthermore, in a syncytia assays, using the gpl6O-vaccinia vector infected
CEM cells, the sera from HIV-BA immunized mice gave very strong inhibition.
CD4-depleted mice did not respond at all to unconjugated HIV I, but did
respond to the HIV-Ba conjugate. The ab produced were of the IgM and some
IgG2a isotype. These sera also neutralized the syncytia assay. A similar
approach is now used to test the immunogenicity of cloned gpl6O conjugated
to Ba. We are also testing the ability of polymerized peptides to generate
T independent IgG responses in athymic (nude) mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV-1 MEDIATED MEMBRANE FUSION AS TARGET OF ANTI-VIRAL THERAPY
-
批准号:2568922
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF ANTI-HIV-1 THERAPEUTIC VACCINE
-
批准号:5200713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CHARACTERIZATION OF T CELL RECEPTOR GENES IN ALLOREACTIVE CLONES
-
批准号:3939366
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:
PRODUCTION OF ANTI-HIV-1 VACCINE
-
批准号:3748147
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
GENERATION OF AUTOANTIBODIES IN HIV-1 VACCINE GROUPS
-
批准号:3770316
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV-1 INFECTION AS TARGETS FOR THERAPY
-
批准号:3770315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
STUDIES OF HIV-1 ENV-MEDIATED MEMBRANE FUSION AND SYNCYTIA FORMATION
-
批准号:3804800
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF PEPTIDE-BASED, T CELL INDEPENDENT HIV-1 VACCINE
-
批准号:3804795
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
EVALUATION OF SAFETY OF MONOCLONAL ANTIBODIES AGAINST HIV ENVELOPE AND ITS CELLUL
-
批准号:6293720
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV1 INFECTION AS TARGETS FOR ANTIVIRAL THERAPY
-
批准号:6161239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
Evaluation of vaccinia IgG (VIG) in the protection of mi
-
批准号:6545148
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
Cellular genes as targets for anti-HIV Therapies
-
批准号:6545092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
HIV-1 mediated membrane fusion as target for anti-viral
-
批准号:6678831
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF ANTI-HIV-1 THERAPEUTIC VACCINE
-
批准号:2568923
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV-1 INFECTION AS TARGETS FOR THERAPY
-
批准号:3748144
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
EVALUATION OF NEW CARRIERS AND ADJUVANTS FOR HIV-1 VACCINES.
-
批准号:6293722
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
HIV-1 mediated membrane fusion as target for anti-viral therapy
-
批准号:6433505
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
Evaluation of new carriers and adjuvants for HIV-1 vaccines.
-
批准号:6433506
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
Evaluation of new carriers/adjuvants for HIV-1 vaccines
-
批准号:6545100
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
ANALYSIS OF HIV-1 CELL ENTRY USING CHEMICALLY INDUCED T CELL MUTANTS
-
批准号:3811244
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
海外基金